Oncolysis Tumor microenvironment modulating technology
eTheRNA is developing mRNA-based products mimicking the action of oncolytic viruses.
eTheRNA has formed a consortium with North American and European partners to access tools to develop a novel mRNA vaccine against SARS-CoV-2.
Galileilaan 19, 2845 Niel, Belgium
+32 3 369 17 40
© 2020 Etherna | Studio Hanswijk